Atomo Diagnostics Limited (AT1.AX)
AUD 0.02
(-5.0%)
AUD 0.02
(-5.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -5.42 Million AUD | 41.36% |
| 2023 | -9.24 Million AUD | -33.35% |
| 2022 | -4.72 Million AUD | -25.74% |
| 2021 | -4.69 Million AUD | -67.79% |
| 2020 | -4.05 Million AUD | 41.45% |
| 2019 | -4.86 Million AUD | 21.05% |
| 2018 | -5.77 Million AUD | 13.55% |
| 2017 | -4.53 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -2.49 Million AUD | 11.08% |
| 2024 FY | - AUD | 32.48% |
| 2024 Q2 | -2.88 Million AUD | 25.71% |
| 2023 Q4 | -3.81 Million AUD | 12.0% |
| 2023 Q2 | -4.33 Million AUD | -75.31% |
| 2023 FY | - AUD | -33.35% |
| 2022 Q2 | -3.63 Million AUD | -15.73% |
| 2022 FY | - AUD | -25.74% |
| 2022 Q4 | -2.47 Million AUD | 32.04% |
| 2021 Q2 | -1.71 Million AUD | -342.94% |
| 2021 FY | - AUD | -67.79% |
| 2021 Q4 | -3.14 Million AUD | -83.16% |
| 2020 FY | - AUD | 41.45% |
| 2020 Q4 | -387.41 Thousand AUD | 77.23% |
| 2020 Q2 | -1.7 Million AUD | -16.71% |
| 2019 FY | - AUD | 21.05% |
| 2019 Q4 | -1.45 Million AUD | 36.49% |
| 2019 Q2 | -2.29 Million AUD | 0.0% |
| 2018 FY | - AUD | 13.55% |
| 2017 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 84.963% |
| Adherium Limited | -11.56 Million AUD | 53.102% |
| Aroa Biosurgery Limited | -7.36 Million AUD | 26.312% |
| Anteris Technologies Ltd | -66.9 Million AUD | 91.894% |
| Control Bionics Limited | -5.15 Million AUD | -5.143% |
| CardieX Limited | -6.71 Million AUD | 19.195% |
| Compumedics Limited | 2.78 Million AUD | 294.46% |
| Cochlear Limited | 579.5 Million AUD | 100.936% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -55.321% |
| Cyclopharm Limited | -3.03 Million AUD | -78.704% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -159.347% |
| Nova Eye Medical Limited | -5.97 Million AUD | 9.291% |
| HeraMED Limited | -3.97 Million AUD | -36.541% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 75.202% |
| ImpediMed Limited | -22.05 Million AUD | 75.405% |
| InhaleRx Limited | -1.41 Million AUD | -283.627% |
| LBT Innovations Limited | -4.04 Million AUD | -33.946% |
| Micro-X Limited | -14.35 Million AUD | 62.208% |
| Neurotech International Limited | -8.24 Million AUD | 34.213% |
| OncoSil Medical Limited | -11.97 Million AUD | 54.714% |
| PolyNovo Limited | 5.17 Million AUD | 204.903% |
| Respiri Limited | -7.04 Million AUD | 23.07% |
| SomnoMed Limited | -2.32 Million AUD | -132.907% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 40.338% |
| Uscom Limited | -1.5 Million AUD | -259.336% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -10.292% |